256m
- REVIEWS
Biotech company Regeneron to buy bankrupt 23andMe for $256M
Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company…
Read More » - SECURITY
Regeneron buys 23andMe for $256m after bankruptcy | Business and Economy
Sale of genetic testing company raises concerns about privacy of 23andMe’s 15 million customers. Regeneron Pharmaceuticals has bought the genetic…
Read More »
